Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.
Trial locations(4 sites)
China
Beijing Tiantan Hospital Capital Medical University, Beijing, Beijing Municipality First Hospital of Shanxi Medical University, Taiyuan, Shanxi Tangdu hospital,fourth military medical university, Xi’an, Shanxi Tianjin Medical University General Hospital, Tianjin, Tianjin Municipality